Researchers are continuing in their efforts to find an effective vaccine against the novel coronavirus after a breakthrough in Australia suggesting that ivermectin, a widely available and approved anti-parasitic drug also being used in tests to act as a potential treatment for HIV, dengue and Zika among other diseases, could be effective against Covid-19.
The latest research from a team made up of Monash University's Biomedicine Discovery Institute (BDI) and the Peter Doherty Institute of Infection and Immunity indicated that ivermectin could form the basis of a Covid-19 vaccine given that it has proven successful in in vitro tests against other viruses, although human studies will be required to test its efficacy against the coronavirus.
Comments